[New oral anticoagulants for the prevention of stroke. Open questions in geriatric patients]. (Q52887413)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828994%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

[New oral anticoagulants for the prevention of stroke. Open questions in geriatric patients] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828994%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828994%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

H K Berthold

series ordinal

1

1 reference

9 May 2018

http://europepmc.org/abstract/MED/22828994

publication date

1 August 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828994%20AND%20SRC:MED&resulttype=core&format=json

Zeitschrift fuer Gerontologie und Geriatrie

8 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828994%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828994%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828994%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

498-504

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828994%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00391-012-0377-4

8 February 2020

exact match

0 references

cites work

Anticoagulants for atrial fibrillation: why is the treatment rate so low?

1 reference

https://api.crossref.org/works/10.1007%2FS00391-012-0377-4

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00391-012-0377-4

Dabigatran versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00391-012-0377-4

Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00391-012-0377-4

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00391-012-0377-4

Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00391-012-0377-4

Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00391-012-0377-4

Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00391-012-0377-4

Apixaban versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00391-012-0377-4

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00391-012-0377-4

Self-monitoring of oral anticoagulation: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00391-012-0377-4

Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00391-012-0377-4

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00391-012-0377-4

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00391-012-0377-4

Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00391-012-0377-4

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00391-012-0377-4

Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00391-012-0377-4

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: a Canadian payer perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00391-012-0377-4

Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00391-012-0377-4

Bleeding Risk in Very Old Patients on Vitamin K Antagonist Treatment

21 January 2018

1 reference

12 December 2020

Bleeding Risk with Dabigatran in the Frail Elderly

1 reference

12 December 2020

Newly identified events in the RE-LY trial

1 reference

12 December 2020

Anticoagulant options--why the FDA approved a higher but not a lower dose of dabigatran

1 reference

12 December 2020

Effective anticoagulation therapy: defining the gap between clinical studies and clinical practice.

1 reference

12 December 2020

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

1 reference

12 December 2020

10.1007/S00391-012-0377-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828994%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference